BANK VONTOBEL/CALL/ABBOTT LABORATORIES/115/0.1/21.06.24 Share Price

Warrant

DE000VU9JRL1

Market Closed - Deutsche Boerse AG 19:03:32 31/05/2024 BST
0.004 EUR -20.00% Intraday chart for BANK VONTOBEL/CALL/ABBOTT LABORATORIES/115/0.1/21.06.24
1 month-92.73%
3 months-99.52%
Date Price Change
31/05/24 0.004 -20.00%
30/05/24 0.005 -.--%
29/05/24 0.005 -.--%
28/05/24 0.005 -16.67%
27/05/24 0.006 -25.00%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 07:03 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Vontobel Vontobel
WKN VU9JRL
ISINDE000VU9JRL1
Date issued 05/07/2023
Strike 115 $
Maturity 21/06/2024 (19 Days)
Parity 10 : 1
Emission price 0.57
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1
Lowest since issue 0.004
Spread 0.015
Spread %75.00%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
102.2 USD
Average target price
125.4 USD
Spread / Average Target
+22.69%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW